GO:0006501 C-terminal protein lipidation: Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006501 (C-terminal protein lipidation) describes the covalent attachment of a lipid group to the carboxy-terminus of a protein.
• This modification is essential for membrane anchoring, protein-protein interactions, and subcellular targeting of key signaling proteins.
• Major classes include farnesylation, geranylgeranylation, and palmitoylation at the C-terminus, affecting proteins such as GRK1 and gasdermin D.
• Dysregulation of C-terminal lipidation is linked to coagulation disorders, neurodegeneration, and cancer.
• CRISPR knockout, point-mutation, and knock-in models are powerful tools to dissect the causal roles of lipidation enzymes and substrates.
• Proteomics and lipidomics approaches enable global profiling of C-terminal lipidated proteins in health and disease.
Description
C-terminal protein lipidation (GO:0006501) is a post-translational modification in which a lipid moiety is covalently attached to the carboxy-terminus of a protein. This process is critical for anchoring proteins to cellular membranes, facilitating protein-protein interactions, and regulating signal transduction pathways. Unlike other lipid modifications that occur on internal cysteine residues, C-terminal lipidation specifically targets the C-terminus and often involves prenylation (farnesylation or geranylgeranylation) or palmitoylation. Researchers study this term to understand how proteins are targeted to membranes and how dysregulation contributes to diseases such as cancer, neurodegeneration, and coagulation disorders. The modification is catalyzed by a series of enzymes including farnesyltransferases and geranylgeranyltransferases, and can be reversed by specific thioesterases, making it a dynamic regulatory event. Recent advances in proteomics and CRISPR-based editing have accelerated the discovery of new lipidated proteins and their functional roles.
C-terminal protein lipidation At A Glance
| GO ID | GO:0006501 |
|---|---|
| GO term | C-terminal protein lipidation |
| Ontology | biological_process |
| Synonym | None |
| Major function | Covalent attachment of a lipid group to the carboxy-terminus of a protein, enabling membrane anchoring and protein targeting |
| Substrates | Proteins with C-terminal CaaX motifs or other lipidation signals, such as GRK1 and gasdermin D |
| Key enzymes | Farnesyltransferase, geranylgeranyltransferase, and palmitoyltransferases |
| Cellular location | Cytosol, endoplasmic reticulum, and plasma membrane |
| Related processes | Prenylation, palmitoylation, and membrane trafficking |
What Is GO:0006501?
C-terminal protein lipidation is the covalent attachment of a lipid group to the carboxy-terminus of a protein. This modification typically occurs on cysteine residues within a C-terminal CaaX motif or similar sequences, leading to the addition of farnesyl or geranylgeranyl groups, and can be followed by proteolytic cleavage and methylation. The lipid anchor enables the protein to associate with cellular membranes, influencing its localization and function.
Why Is C-terminal protein lipidation Important in Cell Biology?
C-terminal protein lipidation is a fundamental regulatory mechanism that controls the membrane association and activity of numerous signaling proteins, including small GTPases, heterotrimeric G proteins, and kinases. Defects in this process can lead to mislocalization of proteins, disrupted signal transduction, and disease pathologies such as cancer, neurodegeneration, and bleeding disorders. Understanding C-terminal lipidation is therefore essential for developing targeted therapies and for interpreting genetic variants that affect protein function.
• Regulates membrane targeting of key signaling proteins such as GRK1 and gasdermin D.
• Essential for blood coagulation through tissue factor pathway inhibitor.
• Implicated in neurodegenerative diseases like Alzheimer's via ApoE4 lipidation.
• Plays a role in cancer by affecting Ras and Rho GTPase localization.
• Modulates inflammatory responses through gasdermin D lipidation.
• Influences lipid metabolism and atherosclerosis.
• Provides targets for therapeutic intervention in cardiovascular disease.
• Enables proteomic profiling of lipidated proteins for biomarker discovery.
• Critical for mitochondrial dynamics and quality control.
• Affects host-pathogen interactions, e.g., Mycoplasma pneumoniae.
What Happens During C-terminal protein lipidation?
Recognition of C-terminal motifs
In simple terms: The cell identifies proteins that need a lipid tag by looking at their tail end.
Proteins destined for C-terminal lipidation typically contain a CaaX motif or other C-terminal signals that are recognized by prenyltransferases. This recognition is the first step in the modification process and determines substrate specificity.
Lipid attachment by prenyltransferases
In simple terms: Enzymes attach a lipid molecule to the protein's tail.
Farnesyltransferase and geranylgeranyltransferase I catalyze the covalent attachment of farnesyl or geranylgeranyl groups to the cysteine residue of the CaaX motif. This reaction occurs in the cytosol and is essential for membrane binding.
Proteolytic cleavage and methylation
In simple terms: After the lipid is attached, the last three amino acids are cut off and a methyl group is added.
Following prenylation, the -aaX portion of the CaaX motif is removed by Rce1 protease, and the newly exposed cysteine is methylated by isoprenylcysteine carboxyl methyltransferase (ICMT). These steps increase hydrophobicity and enhance membrane affinity.
Membrane insertion and trafficking
In simple terms: The lipidated protein then sticks to cell membranes and moves to its destination.
The lipid moiety inserts into the lipid bilayer, anchoring the protein to membranes such as the plasma membrane or endoplasmic reticulum. This anchoring is critical for signaling and trafficking of proteins like GRK1 and gasdermin D.
Reversibility and regulation
In simple terms: The lipid tag can be removed by enzymes, making the process reversible.
Thioesterases such as APT1 can remove palmitate groups, allowing dynamic regulation of protein localization. This reversibility is important for processes like cell migration and signal transduction.
Key Genes Involved in GO:0006501 C-terminal protein lipidation
The following genes encode enzymes and substrates involved in C-terminal protein lipidation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FNTA | Farnesyltransferase alpha subunit | Catalyzes farnesylation of CaaX proteins |
| FNTB | Farnesyltransferase beta subunit | Essential for farnesyl transfer |
| PGGT1B | Geranylgeranyltransferase I beta subunit | Geranylgeranylation of Rho GTPases |
| RCE1 | CaaX protease | Removes -aaX after prenylation |
| ICMT | Isoprenylcysteine carboxyl methyltransferase | Methylates prenylated cysteine |
| GRK1 | G protein-coupled receptor kinase 1 | Farnesylation critical for membrane binding |
| GSDMD | Gasdermin D | Lipid binding and oligomerization in pyroptosis |
| TFPI | Tissue factor pathway inhibitor | Coagulation regulation via lipidation |
| APOE | Apolipoprotein E | Lipidation affects Alzheimer's risk |
| VPS13B | Vacuolar protein sorting 13 homolog B | Lipid vesicle recruitment in mitochondria |
| SP-A | Surfactant protein A | C-terminal domain binds phospholipids |
| P116 | Mycoplasma pneumoniae lipoprotein | Targets liver and atherosclerotic lesions |
| ZDHHC2 | Palmitoyltransferase | Palmitoylation of C-terminal cysteines |
| LYPLA1 | Lysophospholipase 1 | Depalmitoylation enzyme |
| RABGGTA | Rab geranylgeranyltransferase alpha | Geranylgeranylation of Rab proteins |
| RABGGTB | Rab geranylgeranyltransferase beta | Rab prenylation |
| CHM | Rab escort protein 1 | Presents Rab proteins for prenylation |
How Is C-terminal protein lipidation Regulated?
C-terminal protein lipidation is regulated at multiple levels. The availability of lipid substrates (farnesyl pyrophosphate, geranylgeranyl pyrophosphate) influences prenylation rates. Enzymes such as farnesyltransferase and geranylgeranyltransferase are subject to transcriptional and post-translational regulation. Additionally, thioesterases like APT1 can remove lipid groups, providing reversibility. In disease contexts, altered expression of lipidation enzymes has been observed, e.g., in cancer and neurodegeneration.
C-terminal protein lipidation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TFPI | Coagulation disorders | Knockout mice or cell lines |
| APOE | Alzheimer's disease | ApoE4 knock-in mice |
| GSDMD | Inflammatory diseases | GSDMD knockout macrophages |
| GRK1 | Retinal degeneration | GRK1 point-mutation models |
| VPS13B | Mitochondrial dysfunction | VPS13B knockout cells |
C-terminal lipidation in coagulation disorders
Tissue factor pathway inhibitor (TFPI) requires C-terminal lipidation for its cofactor-dependent regulation of coagulation initiation. Dysregulation of TFPI lipidation can lead to bleeding or thrombotic tendencies.
Neurodegeneration and ApoE4
ApoE4, a major genetic risk factor for Alzheimer's disease, requires lipidation enhancement to resolve cellular lipid and protein abnormalities following NPC1 inhibition. Impaired lipidation of ApoE4 may contribute to neurodegeneration.
Cancer and Ras signaling
C-terminal lipidation is essential for the membrane localization of Ras and Rho GTPases, which are frequently mutated in cancer. Inhibitors of farnesyltransferase have been explored as anticancer agents.
Inflammatory diseases and gasdermin D
Gasdermin D undergoes lipid binding and oligomerization to form pores in pyroptosis, a form of inflammatory cell death. C-terminal lipidation may regulate its membrane targeting.
From C-terminal protein lipidation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does farnesylation of GRK1 affect membrane binding? | Point mutation of C-terminal cysteine in GRK1 |
| What is the role of TFPI lipidation in coagulation? | Knockout of TFPI in endothelial cells |
| How does ApoE4 lipidation impact Alzheimer's pathology? | ApoE4 knock-in mice with lipidation enhancers |
| Is gasdermin D lipidation required for pyroptosis? | GSDMD knockout and point-mutation macrophages |
| What proteins are C-terminally lipidated in cancer? | Overexpression of farnesyltransferase in cancer cell lines |
| Does VPS13B regulate mitochondrial lipid trafficking? | VPS13B knockout HeLa cells |
How to Study the C-terminal protein lipidation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry | Identification of lipidated peptides | Global profiling of C-terminal lipidation |
| Click chemistry | Enrichment of alkyne-tagged lipids | Detection of farnesylated proteins |
| Liposome binding assay | Protein-lipid interaction | Membrane binding of GRK1 |
| CRISPR knockout screen | Gene requirement for lipidation | Discovery of new lipidation enzymes |
| Fluorescence microscopy | Subcellular localization | Membrane targeting of gasdermin D |
| Immunoprecipitation | Protein-protein interactions | Isolation of lipidated protein complexes |
| Western blot | Protein expression and modification | Validation of lipidation status |
Proteomic profiling of lipidated proteins
Mass spectrometry-based proteomics can identify C-terminally lipidated proteins by enriching for lipid modifications using click chemistry or biotinylation. This approach has revealed hundreds of novel lipidated proteins.
Lipid binding assays
Lipid overlay assays and liposome binding assays measure the affinity of proteins for specific lipids, as demonstrated for gasdermin D and GRK1.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes required for C-terminal lipidation and membrane targeting.
Fluorescence microscopy
GFP-tagged proteins and fluorescent lipid analogs allow visualization of membrane localization and trafficking in live cells.
How CRISPR Can Be Used to Study GO:0006501 C-terminal protein lipidation
Knockout
CRISPR knockout of genes such as FNTA, FNTB, or RCE1 can abolish C-terminal lipidation, leading to protein mislocalization and loss of function. These models are useful for studying the consequences of lipidation defects in cancer and coagulation.
Point Mutation
Introducing point mutations in the C-terminal CaaX motif (e.g., Cys to Ser) prevents lipidation and allows assessment of its role in membrane binding and signaling. Such models have been used for GRK1 and gasdermin D.
Knock-in
Knock-in of tagged or mutant versions of lipidation enzymes (e.g., GFP-FNTA) enables live-cell imaging and biochemical tracking of lipidation dynamics.
Overexpression
Overexpression of farnesyltransferase or geranylgeranyltransferase can enhance lipidation of target proteins, mimicking disease states such as cancer. This approach helps identify downstream effects of hyper-lipidation.
How EDITGENE Supports C-terminal protein lipidation Research
Researchers studying C-terminal protein lipidation-related genes often need to determine whether a candidate gene is causally involved in membrane targeting, signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for C-terminal protein lipidation research.
Frequently Asked Questions About C-terminal protein lipidation
What is C-terminal protein lipidation?
C-terminal protein lipidation is the covalent attachment of a lipid group to the carboxy-terminus of a protein, which helps anchor it to cell membranes.
What genes are involved in C-terminal protein lipidation?
Key genes include FNTA, FNTB, PGGT1B, RCE1, ICMT, and ZDHHC2, which encode enzymes that catalyze or regulate the modification.
What is the GO ID for C-terminal protein lipidation?
The GO ID is GO:0006501.
How does C-terminal lipidation affect protein function?
It enables membrane targeting, protein-protein interactions, and signal transduction, as seen with GRK1 and gasdermin D.
What diseases are linked to C-terminal protein lipidation?
Diseases include coagulation disorders, Alzheimer's disease, cancer, and inflammatory conditions.
What methods are used to study C-terminal lipidation?
Methods include mass spectrometry, click chemistry, liposome binding assays, and CRISPR screens.
Can CRISPR be used to study C-terminal lipidation?
Yes, CRISPR knockout, point mutation, and knock-in models are widely used to dissect the roles of lipidation enzymes and substrates.
What is the role of farnesylation in C-terminal lipidation?
Farnesylation is a type of C-terminal lipidation that attaches a farnesyl group to cysteine residues in CaaX motifs, critical for membrane binding.
How is C-terminal lipidation regulated?
It is regulated by substrate availability, enzyme expression, and reversible thioesterases like APT1.
Why is C-terminal lipidation important for drug discovery?
It is a target for anticancer and cardiovascular drugs, as inhibiting lipidation can mislocalize oncogenic proteins like Ras.
Conclusion
C-terminal protein lipidation (GO:0006501) is a crucial post-translational modification that controls membrane targeting and signaling of diverse proteins. Its dysregulation is implicated in cancer, neurodegeneration, and coagulation disorders, making it a promising therapeutic target. Advances in CRISPR editing and proteomics continue to uncover new roles for this modification, offering opportunities for drug discovery and personalized medicine.
References
- 1. Meinnel T et al.. 2008. Protein lipidation meets proteomics.. Front Biosci 13:6326-40 PMID: 18508663
- 2. Ahnström J et al.. 2024. Tissue factor pathway inhibitor - cofactor-dependent regulation of the initiation of coagulation.. Curr Opin Hematol 31(6):315-320 PMID: 39259668
- 3. Millette MA et al.. 2022. Farnesylation and lipid unsaturation are critical for the membrane binding of the C-terminal segment of G-Protein Receptor Kinase 1.. Colloids Surf B Biointerfaces 211:112315 PMID: 35026543
- 4. Lee SK et al.. 2025. VPS13B recruits lipid vesicles to promote mitochondrial fission and quality control.. Nat Commun 17(1):747 PMID: 41402289
- 5. Murata Y et al.. 1993. Role of the C-terminal domain of pulmonary surfactant protein A in binding to alveolar type II cells and regulation of phospholipid secretion.. Biochem J 291 ( Pt 1)(Pt 1):71-6 PMID: 8471056
- 6. Liu Z et al.. 2019. Crystal Structures of the Full-Length Murine and Human Gasdermin D Reveal Mechanisms of Autoinhibition, Lipid Binding, and Oligomerization.. Immunity 51(1):43-49.e4 PMID: 31097341
- 7. Vizarraga D et al.. 2025. Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions.. Nat Commun 16(1):11159 PMID: 41402265
- 8. Di Biase E et al.. 2025. ApoE4 requires lipidation enhancement to resolve cellular lipid and protein abnormalities following NPC1 inhibition.. Sci Rep 15(1):15051 PMID: 40301465
